Vera Therapeutics
Sells TRUTAKNA and develops immune-mediated kidney disease treatments.
$33.91
After-hours close−0.26 (−0.76%)
At close$34.17(−1.24%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.61 | — | — |
| Aug 2026 | −$1.58 | −$1.52 | +3.8% |
| May 2026 | −$1.33 | −$1.69 | −27.2% |
| Feb 2026 | −$1.34 | −$1.39 | −3.7% |
| Nov 2025 | −$1.20 | −$1.26 | −5.0% |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| Jun 2021 | |||
| Apr 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$1.61 | — | — | $4.3M | — | — |
| Aug 10, 2026 | −$1.58 | −$1.52 | +3.8% | $1.3M | — | — |
| May 7, 2026 | −$1.33 | −$1.69 | −27.2% | $426.0K | — | — |
| Feb 26, 2026 | −$1.34 | −$1.39 | −3.7% | — | — | — |
| Nov 5, 2025 | −$1.20 | −$1.26 | −5.0% | — | — | — |
The latest year is open to everyone — the 22 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 20, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 28, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 10, 2022 | ||||||
| May 16, 2022 | ||||||
| Mar 24, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 16, 2021 | ||||||
| Jun 24, 2021 | ||||||
| Apr 23, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||